ArticleScientific reports2026
Attenuation without protective immunogenicity: effects of codon-pair deoptimization on foot-and-mouth disease virus serotype O in swine.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Foot-and-mouth-disease (FMD), caused by the FMD virus, is a contagious disease affecting cloven-hoofed animals. Since outbreaks often cause significant economic impact, control and prevention measures against FMDV, such as vaccines, are urgently needed especially in endemic regions. The use of inactivated whole-virus vaccines has led to the eradication of FMD in many industrialized nations. Nonetheless, recent outbreaks in Europe have highlighted the virus's potential for rapid spread and its capacity to inflict substantial economic losses. Codon pair deoptimization is a novel strategy for viral attenuation. In this study, we report the first application of this approach to the P1 capsid coding region of FMDV serotype O. A recombinant virus carrying the deoptimized P1 region was attenuated in vitro, as evidenced by reduced replication capacity in porcine LFBK-αvβ6 cells. In vivo evaluations further demonstrated that a substantially higher dose was required to induce clinical disease in pigs than with wild-type viruses. However, immunization with lower and innocuous doses did not result in protective immunity. These findings underscore both the potential and the challenges of utilizing codon pair deoptimization for developing safe and effective FMDV vaccine candidates, emphasizing that further optimization is necessary to achieve a desirable balance between attenuation and immunogenicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.